longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CASI

CASI
0.20750.00%( 0.0000 )

LongbridgeAI

CASI Pharmaceuticals shares are trading lower after the company announced receipt of delisting decision from the Nasdaq.

benzinga_article
Feb 25, 2026 at 06:20 PM
CASI Pharmaceuticals shares are trading lower after the company announced receipt of delisting decision from the Nasdaq.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Oct 1, 2026 at 04:29 PMStock Market Today: S&P 500 Slips as Micron Fails to Impress, 10-Year Yields Ease to 5.25%
  • Aug 31, 2026 at 05:20 PMTrump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers
  • Aug 26, 2026 at 03:08 PMHotter PCE Inflation: 5 Defensive ETFs Investors Can Turn to as Rate-Cut Hopes Fade
  • Aug 20, 2026 at 12:49 AMMerck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For
  • Jul 22, 2026 at 01:38 PMTrump Says US To Exempt Import Tariff On Generic Drugs For Two Years

Related Stocks

CASI Pharmaceuticals

CASI Pharmaceuticals

USCASI

0.00%

iShares US Pharma

iShares US Pharma

USIHE

VG Health

VG Health

USVHT